Tech Company Financing Transactions
Cognition Therapeutics Funding Round
On 7/16/2009, Cognition Therapeutics raised $1.2 million in Series A funding from Ogden CAP and private investors.
Transaction Overview
Company Name
Announced On
7/16/2009
Transaction Type
Venture Equity
Amount
$1,210,000
Round
Series A
Investors
Ogden CAP (Lead Investor)
Proceeds Purpose
Cognition will use these funds to test its most promising lead molecules in behavioral models of Alzheimer's disease.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2403 Sidney St. 261
Pittsburgh, PA 15203
USA
Pittsburgh, PA 15203
USA
Phone
Website
Email Address
Overview
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimers disease and other neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Moch
Chief Financial Officer
Stephen DiPalma
Chief Medical Officer
Gilbert Rishton
Chief Scientific Officer
Susan Catalano
Browse more venture capital transactions:
Prev: 7/16/2009: Truviso venture capital transaction
Next: 7/17/2009: PriceDrip venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs